These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25898260)

  • 1. Concerns expressed by parents of children with pervasive developmental disorders for different time periods of the day: a case-control study.
    Sasaki Y; Usami M; Sasayama D; Okada T; Iwadare Y; Watanabe K; Ushijima H; Tanaka T; Harada M; Tanaka H; Kodaira M; Sugiyama N; Sawa T; Saito K
    PLoS One; 2015; 10(4):e0124692. PubMed ID: 25898260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-control study of the difficulties in daily functioning experienced by children with depressive disorder.
    Usami M; Iwadare Y; Watanabe K; Ushijima H; Kodaira M; Okada T; Sasayama D; Sugiyama N; Saito K
    J Affect Disord; 2015 Jul; 179():167-74. PubMed ID: 25863914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What time periods of the day are concerning for parents of children with attention deficit hyperactivity disorder?
    Usami M; Okada T; Sasayama D; Iwadare Y; Watanabe K; Ushijima H; Kodaira M; Sugiyama N; Sawa T; Saito K
    PLoS One; 2013; 8(11):e79806. PubMed ID: 24224007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of attention-deficit/hyperactivity disorder symptoms in male children with high-functioning pervasive developmental disorders.
    Matsushima N; Miyawaki D; Tsuji H; Takahashi K; Horino A; Kawaguchi T; Suzuki F; Kiriike N
    Osaka City Med J; 2008 Jun; 54(1):1-10. PubMed ID: 18819260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reliability and validity of the Questionnaire - Children with Difficulties (QCD).
    Usami M; Sasayama D; Sugiyama N; Hosogane N; Kim SY; Yamashita Y; Kodaira M; Watanabe K; Iwadare Y; Sawa T; Saito K
    Child Adolesc Psychiatry Ment Health; 2013 Mar; 7(1):11. PubMed ID: 23537143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of attention deficit hyperactivity disorder-like symptoms on the clinical features of adolescents with pervasive developmental disorders.
    Suzumura S
    Asia Pac Psychiatry; 2014 Mar; 6(1):71-6. PubMed ID: 23857705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comorbidity of Pervasive Developmental Disorder and Attention Deficit Hyperactivity Disorder: results of a retrospective chart review.
    Goldstein S; Schwebach AJ
    J Autism Dev Disord; 2004 Jun; 34(3):329-39. PubMed ID: 15264500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pervasive developmental disorder with attention deficit hyperactivity disorder-like symptoms and mismatch negativity.
    Sawada M; Negoro H; Iida J; Kishimoto T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):479-81. PubMed ID: 18778448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders.
    Lee DO; Ousley OY
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):737-46. PubMed ID: 17201617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Score of inattention subscale of ADHD rating scale-IV is significantly higher for AD/HD than PDD.
    Fujibayashi H; Kitayama S; Matsuo M
    Kobe J Med Sci; 2010 Aug; 56(1):E12-7. PubMed ID: 21063141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the daily life of child and adolescent psychiatric outpatients during temporary school closure over COVID-19 pandemic: A single-center case-control study in Japan.
    Sasaki Y; Sasaki S; Sunakawa H; Toguchi Y; Tanese S; Saito K; Shinohara R; Kurokouchi T; Sugimoto K; Itagaki K; Yoshida Y; Namekata S; Takahashi M; Harada I; Hakosima Y; Inazaki K; Yoshimura Y; Mizumoto Y; Okada T; Usami M
    Glob Health Med; 2022 Jun; 4(3):159-165. PubMed ID: 35855068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study.
    Troost PW; Steenhuis MP; Tuynman-Qua HG; Kalverdijk LJ; Buitelaar JK; Minderaa RB; Hoekstra PJ
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):611-9. PubMed ID: 17069549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quality of life of children with pervasive developmental disorders.
    Montalbano R; Roccella M
    Minerva Pediatr; 2009 Aug; 61(4):361-70. PubMed ID: 19752845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pervasive developmental disorder behavior in adolescents with intellectual disability and co-occurring somatic chronic diseases.
    Oeseburg B; Groothoff JW; Dijkstra GJ; Reijneveld SA; Jansen DE
    Res Dev Disabil; 2010; 31(2):496-501. PubMed ID: 19948390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
    Kim HW; Cho SC; Kim BN; Kim JW; Shin MS; Yeo JY
    Compr Psychiatry; 2010; 51(4):412-8. PubMed ID: 20579516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation between attention-deficit/hyperactivity disorder and pervasive developmental disorders with hyperactivity on objective activity levels using actigraphs.
    Tsujii N; Okada A; Kaku R; Kuriki N; Hanada K; Shirakawa O
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):336-43. PubMed ID: 19566765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical necessity for assessing Attention Deficit/Hyperactivity Disorder (AD/HD) symptoms in children with high-functioning Pervasive Developmental Disorder (PDD).
    Yoshida Y; Uchiyama T
    Eur Child Adolesc Psychiatry; 2004 Oct; 13(5):307-14. PubMed ID: 15490278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial.
    Hiscock H; Sciberras E; Mensah F; Gerner B; Efron D; Khano S; Oberklaid F
    BMJ; 2015 Jan; 350():h68. PubMed ID: 25646809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.